Balyasny Asset Management LLC Edwards Lifesciences Corp Put Options Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $1.79 Million - $2.36 Million	24,700 New	24,700 $2.36 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $823,280 - $982,000	-8,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $2.68 Million - $3.35 Million	-32,000 Reduced 80.0%	8,000 $829,000
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $1.92 Million - $2.56 Million	40,000 New	40,000 $7.65 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.